From Chatbots to Digital Colleagues: What Is Agentic AI?
Most of us think of artificial intelligence as a dialogue with a chatbot. You write a query, you get an answer. That's a reactive model. Agentic AI, however, works differently. As defined by Garrett Adams of Fierce Biotech, agentic AI is not just an assistant, but rather a "digital colleague" with the ability to take initiative.
While an ordinary LLM (Large Language Model) waits for your prompt, an agent possesses attributes such as autonomy, memory, and planning capability. It can use external tools, connect via APIs to other systems, and proceed toward a defined goal without a human having to tell it what to do at every step. In clinical development, this means the ability not only to analyze data from medical records, but also to actively detect deviations in clinical trials or automatically communicate with research centers.
Horizontal vs. Vertical AI: Why Specialization Is Critical?
To understand why you can't leave clinical trial management to a standard ChatGPT, we need to distinguish two fundamental approaches: horizontal and vertical AI. This distinction is essential for safety and regulatory compliance.
Horizontal AI (Generalists)
These are general-purpose models such as OpenAI GPT-4o, Google Gemini, or Anthropic Claude. They are extremely capable across a broad spectrum of tasks – from programming to creative writing. They are "horizontal" tools because their knowledge base covers everything from history to physics. Their disadvantage, however, is the lack of deep, verified expertise in narrow medical protocols and a lower degree of control over specific regulatory requirements.
Vertical AI (Specialists)
By contrast, vertical agentic AI is built directly for one specific field – in this case, life sciences. According to an analysis by Medable, these specialists are trained on validated clinical data and must meet strict standards such as 21 CFR Part 11 or HIPAA.
These agents aren't just "smarter." They are designed to:
- Clean and reconcile data in EDC (Electronic Data Capture) systems.
- Manage workflows in CTMS (Clinical Trial Management System) systems.
- Automate and regulate communication with clinical sites while maintaining full auditability.
Real-World Examples: How It Works in Practice
An example of successful deployment is the system at Cedars-Sinai hospital, which uses various forms of AI to streamline physicians' work. According to information from Nabla, these institutions use ambient AI for documentation, dramatically reducing doctors' administrative burden (the so-called "pajama time" – time doctors have to spend on paperwork at home).
Predictive algorithms are also emerging for monitoring maternal and infant health or early detection of sudden cardiac death. Here, it's no longer about creativity, but about extreme precision, where every error can have fatal consequences.
Impact on the Czech Market and EU Regulation
For Czech pharmaceutical companies, research institutes, and hospitals, this technology brings two main challenges: regulation and data security.
In the Czech Republic and across the EU, we must particularly consider the EU AI Act. Systems used in medicine are classified as high-risk. This means that vertical agentic systems must be transparent, auditable, and have clearly defined human oversight. While tools like Nabla (offering ambient assistance) or specialized platforms like Medable are primarily oriented toward the US market, their implementation in the EU will require strict compliance with GDPR and specific European standards for clinical trials.
What does this mean for a Czech company? If you're considering implementing AI in research, don't just look for the "smartest model." Look for a solution that is vertical – one that provides confirmation of compliance with European regulation and guarantees that data remains within the EU.
Comparison: General AI vs. Vertical Medical AI
| Feature | Horizontal (e.g. GPT-4o) | Vertical (Medical Agent) |
|---|---|---|
| Primary Goal | Versatility, creativity | Precision, compliance, safety |
| Context | General (internet-based) | Validated clinical data |
| Regulation | General AI ethics | HIPAA, 21 CFR Part 11, EU AI Act |
| Cost | Free tier / approx. $20/month | Enterprise (custom pricing) |
Conclusion
Agentic AI pushes the boundaries from "an assistant that writes" to "a partner that acts." In medicine, this shift is essential for accelerating drug development and reducing error rates. For Czech professionals, however, it means the necessity of closely monitoring the EU legislative framework and choosing tools built on solid, clinically verified foundations, rather than just on the broad intelligence of models.
Can agentic AI in medicine replace doctors in decision-making?
No. Agentic AI is designed as decision support. Even in the most advanced systems, the final responsibility and control remains in the hands of a qualified professional, as required by EU legislation.
Are these tools available in Czech?
Most specialized vertical systems (such as Medable) are primarily English-language, as they stem from global clinical standards. For the Czech market, however, the key factor is the system's ability to work with European data regulations (GDPR).
What is the cost of implementing vertical AI in a hospital?
Unlike standard subscriptions (e.g. ChatGPT Plus at approx. CZK 480/month), vertical systems are enterprise solutions with custom pricing that depends on the number of users and the extent of integration into hospital systems.
